Patents
Literature
6 results about "Reuptake inhibitor" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
A reuptake inhibitor (RI) is a type of drug known as a reuptake modulator that inhibits the plasmalemmal transporter-mediated reuptake of a neurotransmitter from the synapse into the pre-synaptic neuron. This leads to an increase in extracellular concentrations of the neurotransmitter and an increase in neurotransmission. Various drugs exert their psychological and physiological effects through reuptake inhibition, including many antidepressants and psychostimulants.
Treatment of sleep disorders using triple reuptake inhibitors
PendingCN122094679ANervous disorderHeterocyclic compound active ingredientsTreatment sleepSleeping disorders
This article provides a method for treating sleep disorders (e.g., narcolepsy) in subjects who require it by administering a composition containing a triple reuptake inhibitor to the subject.
Owner:NOEMA PHARMA AG
Novel compounds and serotonin reuptake inhibitors
ActiveJP2026060423ANervous disorderHydroxy compound active ingredientsChemical compoundSerotonin reuptake
The present invention aims to provide a serotonin uptake inhibitor that can exert its effects more efficiently by analyzing the component composition of plants of the genus Valerian. [Solution] The present invention provides a serotonin reuptake inhibitor comprising a compound represented by the following formula (1), and one or more selected from the group consisting of the compound, canoconyl acetate, and α-kesyl acetate as active ingredients. [Formula 1] TIFF2026060423000008.tif50170
Owner:KUKI SANGYO CORP +2
Triple reuptake inhibitors used in the treatment of behavioral immune-metabolic cluster disorders or diseases
PendingCN122094680AFacilitated Diffusiondegree of reductionNervous disorderMetabolism disorderDiseaseReuptake inhibitor
Owner:NOEMA PHARMA AG
Compositions and Methods of Treating Neurological Conditions
Pharmaceutical compositions containing a dopamine Putamen reuptake inhibitor or a dopaminergic agonist, an adrenoceptor antagonist, and a pharmaceutically acceptable carrier, and methods for treating neurological diseases by administering the composition.
Owner:DRI BIOSCIENCES CORP
Aromatic ring coupled bicyclic compound as monoamine transmitter reuptake inhibitor as well as preparation method and application of aromatic ring coupled bicyclic compound
The invention provides a monoamine transmitter reuptake inhibitor as well as a preparation method and a pharmaceutical composition thereof. The invention further relates to application of the compound or the pharmaceutical composition in preparation of drugs for preventing or treating related diseases mediated by dopamine DA, noradrenaline NE and 5-hydroxytryptamine 5-HT.
Owner:SHANDONG QUANZHONG BIOMEDICAL TECHNOLOGY CO LTD